Levozal M Tablet is a combination medicine used in the treatment of allergic symptoms such as runny nose, stuffy nose, sneezing, itching, swelling, watery eyes and congestion or stuffiness. It also reduces inflammation in the airways and make breathing easier.
Levozal M Tablet is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect, or be affected by this medicine.
The most common side effects are nausea, diarrhea, vomiting, dryness in the mouth, headache, skin rash, flu-like symptoms, and fatigue. Most of these are temporary and usually resolve with time. Contact your doctor straight away if you are at all concerned about any of these side effects. This medicine may cause dizziness and sleepiness, so do not drive or do anything that requires mental focus until you know how this medicine affects you. Avoid drinking alcohol while taking this medicine as it can worsen your sleepiness.
Never support self-medication or recommend your medicine to another person. It is beneficial to have plenty of fluids while taking this medication. Before you start taking this medicine it is important to inform your doctor if you are suffering from kidney disease.
USES OF TABLET
- Treatment of Sneezing and runny nose due to allergies
- Treatment of Hay fever
- Treatment of Allergic skin conditions
BENEFITS OF TABLET
In Treatment of Sneezing and runny nose due to allergies
In Treatment of Hay fever
In Treatment of Allergic skin conditions
SIDE EFFECTS OF TABLET
Common side effects
- Dryness in mouth
- Skin rash
HOW TO USE TABLET
HOW TABLET WORKS
Use of tablet is not recommended in patients with severe kidney disease.
Limited information is available on the use of tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.